Opinion statement Gastric cancer is an aggressive malignancy, requiring a multimodality
approach to achieve optimal curative rates even when the disease is amenable to surgical …

Although surgical resection remains the only potentially curative treatment for gastric cancer
(GC), poor long-term outcomes with resection alone compel a multimodality approach to this …

Neoadjuvant chemotherapy has recently received increasing attention in an attempt to
increase the rate of complete tumor resections, combat systemic metastases, and prolong …

Surgery is still the only curative therapy for locoregional gastric cancer. Hereby it is important
to achieve negative margins (R0 resection) and to perform an adequate lymph-node …

Abstract Background and Aim Although the effect of neoadjuvant chemotherapy in gastric
cancer has been extensively studied, the data of survival benefit are still controversial. The …

The management of gastric cancer continues to evolve. Whilst surgery alone is effective
when tumours present early, a large proportion of patients are diagnosed with loco …

Gastric cancer still represents one of the major causes of cancer mortality worldwide.
Patients survival is mainly related to stage, with a high proportion of patients with metastatic …

Gastric cancer is an important problem and is worldwide one of the most frequently-
diagnosed cancers [1, 2]. Although the incidence of gastric cancer has been declining in the …

Abstract Treatment of metastatic and locally advanced gastric cancer and the surgical
treatment of cancer in earlier stages, with or without chemotherapy, is discussed in this …

In the past, the role of adjuvant therapy for gastric cancer was indefinite. However, three
large, randomized controlled trials have recently shown the survival benefit of adjuvant …